The micro-breaks in the building blocks of vertebra mainly caused by bone-thinning are termed as vertebral compression fractures (VCFs). Vertebral compression fracture occurs due to compression of a single bone due to trauma. The surgical approach for VCF treatment comprises injecting bone cement through a small hole in the fractured vertebra to provide immediate pain relief and stabilization to the patient. The cementing material provides a scaffold for the spine bone for added support. Thinning of corticles, reduction in bone mineral density, and osteoporosis are the major factors causing vertebral compression fractures. Postmenopausal women are more prone to vertebral fractures. The ultimate goal of the vertebral compression fracture devices is to eliminate back pain, fuse and repair fractures, restore posture, and provide ease of movement.

Kyphoplasty and vertebroplasty are the evolved techniques of osteoporotic compression. Kyphoplasty is done on patients with severe pain even after weeks of non-operative or drug-related treatment. The technique involves expansion for cavity formation and cement injection that can be done with less pressure. Vertebroplasty is not generally recommended by American Academy of Orthopaedic Surgeons (AAOS), owing to the higher rates of extravasation and increased complications with no beneficial effects.

Rising prevalence of osteoporosis drives the vertebral compression fracture devices market

According to the International Osteoporosis Foundation estimates in 2010, osteoporosis affects 200 million people globally with approximate 9 million new osteoporotic fractures, with 1.6 million hip fractures, 1.7 million forearm fractures, and 1.4 million clinical vertebral fractures. The rising incidence of arthritis and osteoporosis, inability of medicinal therapy to cure vertebral compression fracture to the optimum level, and the advent of minimally invasive spine surgeries drives the growth of vertebral compression fracture devices market. Moreover, short recovery period, low risk of infection, limited hospital stay, and rise in geriatric population are projected to boost the demand for VCF devices globally. However, stringent regulatory approval process and the risk of post-surgical complications such as neurological injury and compromised pulmonary function are expected to restrain the market growth.

Balloon kyphoplasty devices segment is expected to procure largest revenue owing to its beneficial effects

The global vertebral compression fracture devices market is segmented on the basis of technology, diagnosis, surgery, end user, and geography.

On the basis of technology, the global vertebral compression fracture devices market is segmented into:

Balloon Kyphoplasty Devices

Vertebroplasty Devices

On the basis of diagnosis, the global vertebral compression fracture devices market is segmented into:

X-rays, CT scan or MRI

Radio Scan

On the basis of surgery, the global vertebral compression fracture devices market is segmented into:

Open Spine Surgery

Minimally Invasive Spine Surgery

Lumbar Fusion

On the basis of end user, the global vertebral compression fracture devices market is segmented into:

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others

Asia Pacific is projected to grow rapidly with the rise in healthcare expenditures to cater the unmet medical needs

Regional segmentation of the global VCF market by Coherent Market Insights comprises North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. According to the World Health Organization estimates in 2015, vertebral compression fractures (VCF) are the common type of fragility fractures with 700,000 VCF cases per year in the U.S., with 30% postmenopausal women likely to experience humerus, hip, and spine fractures, thereby propelling the demand for innovative VCF devices. North America is expected to dominate the global market, owing to the surge in procedure volumes, rising prevalence of impairments, spinal disorders such as spinal stenosis, well-defined reimbursement policies, supportive economic base, and high awareness of VCF conditions and treatments available. Asia Pacific is projected to grow rapidly during the forecast period due to the improving healthcare infrastructures, increasing healthcare expenditures in the emerging economies such as China and India to cater the unmet medical needs and rise in general awareness.

Delivering high quality minimally invasive products is expected to push the manufacturing envelope

Key players operating in the global vertebral compression fracture devices market include Alphatec Holdings, Inc., Depuy Synthes, Osseon LLC, VEXIM SA, and Orthovita, Inc. The launch of innovative CurvePlus device and InterV line offers atraumatic treatment allowing pain management clinics to have a safer and quicker procedure. Other key vendors include Stryker Corporation, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., DFine, Inc. and CareFusion Corporation.